• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Keith R. Solomon, PhD


  • Solomon KR, Allott EH, Freeman MR, Freedland SJ.Re: Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer Through Loss of ABCA1.Eur Urol. 2013 Jun;63(6):1128-9.
  • Freeman MR, Solomon KR.Statin Drugs and Prostate Cancer: Time to Consider Proactive Strategies in Patients.J Urol. 2013 Jan 18.
  • Hager MH, Morley S, Bielenberg DR, Gao S, Morello M, Holcomb IN, Liu W, Mouneimne G, Demichelis F, Kim J, Solomon KR, Adam RM, Isaacs WB, Higgs HN, Vessella RL, Di Vizio D, Freeman MR.DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.EMBO Mol Med. 2012 Aug;4(8):743-60.
  • Pelton K, Freeman MR, Solomon KR.Cholesterol and prostate cancer.Curr Opin Pharmacol. 2012 Jul 21.
  • Kim J, Di Vizio D, Kim TK, Kim J, Kim M, Pelton K, Clinton SK, Hai T, Hwang D, Solomon KR, Freeman MR.The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing network.PLoS ONE. 2012;7(7):e39448.
  • Mostaghel EA, Solomon KR, Pelton K, Freeman MR, Montgomery RB.Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.PLoS ONE. 2012;7(1):e30062.
  • Freeman MR, Solomon KR.Cholesterol and benign prostate disease.Differentiation.;82(4-5):244-52.
  • Solomon KR, Freeman MR.The complex interplay between cholesterol and prostate malignancy.Urol Clin North Am. 2011 Aug;38(3):243-59. Review.
  • Pelton K, Di Vizio D, Insabato L, Schaffner CP, Freeman MR, Solomon KR.Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia.J Urol. 2010 Oct;184(4):1555-9.
  • Di Vizio D,Solomon KR,Freeman MR.Cholesterol and cholesterol-rich membranes in prostate cancer: an update.Tumori. 2008 Sep-Oct;94(5):633-9. Review.
  • Hager MH, Solomon KR, Freeman MR.The role of cholesterol in prostate cancer.Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):379-85. Review.
  • Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR.Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.J Clin Invest. 2005 Apr;115(4):959-68.
  • Freeman MR, Solomon KR.Cholesterol and prostate cancer.J Cell Biochem. 2004 Jan 1;91(1):54-69.
  • Kim J, Adam RM, Solomon KR, Freeman MR.Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.Endocrinology. 2004 Feb;145(2):613-9.
  • Zhuang L, Lin J, Lu ML, Solomon KR, Freeman MR.Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.Cancer Res. 2002 Apr 15;62(8):2227-31.